These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 30062502)

  • 1. BMP1 5'UTR + 104 T/C gene variation: can be a predictive marker for serum HDL and apoprotein A1 levels in male patients with coronary heart disease.
    Akadam-Teker B; Ozkara G; Kurnaz-Gomleksiz O; Bugra Z; Teker E; Ozturk O; Yilmaz-Aydogan H
    Mol Biol Rep; 2018 Oct; 45(5):1269-1276. PubMed ID: 30062502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interactions of several single nucleotide polymorphisms and high body mass index on serum lipid traits.
    Yin RX; Wu DF; Miao L; Htet Aung LH; Cao XL; Yan TT; Long XJ; Liu WY; Zhang L; Li M
    Biofactors; 2013; 39(3):315-25. PubMed ID: 23355348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the APOA1 rs964184 SNP and serum lipid traits in the Chinese Maonan and Han populations.
    Qiu L; Yin RX; Khounphinith E; Zhang FH; Yang DZ; Pan SL
    Lipids Health Dis; 2018 May; 17(1):105. PubMed ID: 29747660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MspI polymorphism at +83 bp in intron 1 of the human apolipoprotein A1 gene is associated with elevated levels of HDL cholesterol and apolipoprotein A1 in nondiabetic subjects but not in type 2 diabetic patients with coronary heart disease.
    Pulkkinen A; Viitanen L; Kareinen A; Lehto S; Laakso M
    Diabetes Care; 2000 Jun; 23(6):791-5. PubMed ID: 10840998
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apolipoprotein A1 gene polymorphisms and risk of early coronary disease.
    Reguero JR; Cubero GI; Batalla A; Alvarez V; Hevia S; Cortina A; Coto E
    Cardiology; 1998 Dec; 90(3):231-5. PubMed ID: 9892774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol before routine clinical lipid measurement in predicting coronary heart disease.
    Pan L; Lu G; Chen Z
    Coron Artery Dis; 2014 Aug; 25(5):433-8. PubMed ID: 24608795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel polymorphisms in promoter region of atp binding cassette transporter gene and plasma lipids, severity, progression, and regression of coronary atherosclerosis and response to therapy.
    Lutucuta S; Ballantyne CM; Elghannam H; Gotto AM; Marian AJ
    Circ Res; 2001 May; 88(9):969-73. PubMed ID: 11349008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
    Liting P; Guoping L; Zhenyue C
    Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCA1 gene polymorphisms and their associations with coronary artery disease and plasma lipids in males from three ethnic populations in Singapore.
    Tan JH; Low PS; Tan YS; Tong MC; Saha N; Yang H; Heng CK
    Hum Genet; 2003 Jul; 113(2):106-17. PubMed ID: 12709788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of ATP binding cassette transporter G8 rs4148217 SNP and serum lipid levels in Mulao and Han nationalities.
    Li Q; Wei XL; Yin RX
    Lipids Health Dis; 2012 May; 11():46. PubMed ID: 22548731
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of apolipoprotein A1 genetic polymorphisms on lipid profiles and the risk of coronary artery disease.
    Liao B; Cheng K; Dong S; Liu H; Xu Z
    Diagn Pathol; 2015 Jul; 10():102. PubMed ID: 26173491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of Apolipoprotein B/A1 ratio, Framingham risk score and TC/HDL-c for predicting clinical outcomes in patients undergoing percutaneous coronary intervention.
    Tian M; Li R; Shan Z; Wang DW; Jiang J; Cui G
    Lipids Health Dis; 2019 Nov; 18(1):202. PubMed ID: 31744496
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An association analysis between ApoA1 polymorphisms and the high-density lipoprotein (HDL) cholesterol level and myocardial infarction (MI) in Japanese.
    Shioji K; Mannami T; Kokubo Y; Goto Y; Nonogi H; Iwai N
    J Hum Genet; 2004; 49(8):433-439. PubMed ID: 15258834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compound heterozygosity for a structural apolipoprotein A-I variant, apo A-I(L141R)Pisa, and an apolipoprotein A-I null allele in patients with absence of HDL cholesterol, corneal opacifications, and coronary heart disease.
    Miccoli R; Bertolotto A; Navalesi R; Odoguardi L; Boni A; Wessling J; Funke H; Wiebusch H; Eckardstein A; Assmann G
    Circulation; 1996 Oct; 94(7):1622-8. PubMed ID: 8840853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of the LIPG 584C>T polymorphism and alcohol consumption on serum lipid levels.
    Liu WY; Yin RX; Zhang L; Wu DF; Htet Aung LH; Hu XJ; Cao XL; Miao L
    Alcohol; 2011 Nov; 45(7):681-7. PubMed ID: 21816559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lower plasma apolipoprotein A1 levels are found in Parkinson's disease and associate with apolipoprotein A1 genotype.
    Swanson CR; Li K; Unger TL; Gallagher MD; Van Deerlin VM; Agarwal P; Leverenz J; Roberts J; Samii A; Gross RG; Hurtig H; Rick J; Weintraub D; Trojanowski JQ; Zabetian C; Chen-Plotkin AS
    Mov Disord; 2015 May; 30(6):805-12. PubMed ID: 25227208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interactions of six SNPs in APOA1 gene and types of obesity on low HDL-C disease in Xinjiang pastoral area of China.
    Wang X; He J; Guo H; Mu L; Hu Y; Ma J; Yan Y; Ma R; Li S; Ding Y; Zhang M; Niu Q; Liu J; Zhang J; Guo S
    Lipids Health Dis; 2017 Oct; 16(1):187. PubMed ID: 28969676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
    Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
    Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying functional non-coding variants in APOA5/A4/C3/A1 gene cluster associated with coronary heart disease.
    Cui G; Tian M; Hu S; Wang Y; Wang DW
    J Mol Cell Cardiol; 2020 Jul; 144():54-62. PubMed ID: 32437778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pitavastatin: novel effects on lipid parameters.
    Chapman MJ
    Atheroscler Suppl; 2011 Nov; 12(3):277-84. PubMed ID: 22152282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.